Pet healthcare company Animalcare Group has been acquired by private equity firm Charterhouse Capital Partners.
Headquartered in York, United Kingdom, Animalcare specialises in the development and commercialisation of products for companion animals, equine and production animals. The Group holds around 150 animal health pharma brands, with core franchises in dental, equine and pain products with a strong presence in Europe and the Asia-Pacific region. The acquisition by Charterhouse follows the delisting of Animalcare from the London Stock Exchange (AIM) and its re-registration as a private company.
Charterhouse will partner with current chief executive Jennifer Winter and the existing management team to accelerate international expansion, strengthen the company’s product pipeline and deliver sustainable long-term growth, the firm explained.
Haitham Nasri, partner at Charterhouse Capital Partners, said: “We are delighted that Animalcare Group is joining our portfolio, and to partner with Jennifer, the management team and all of the company’s employees.
“Animalcare Group has built an outstanding platform in an attractive and resilient market, underpinned by differentiated products, strong scientific capabilities and an ambitious growth strategy. We look forward to working closely with the team to support continued investment in innovation, international expansion and strategic acquisitions to realise Animalcare Group’s long-term growth ambitions.”
